Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Deep Vein Thrombosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Hereditary Antithrombin Deficiency
|
0.340 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Thrombosis
|
0.510 |
Therapeutic
|
phenotype |
CTD_human |
[Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
|
8967151 |
1996 |
Thrombosis
|
0.510 |
Biomarker
|
phenotype |
CTD_human |
[Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
|
8967151 |
1996 |
Thrombus
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
[Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
|
8967151 |
1996 |
Thrombus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
|
8967151 |
1996 |
Disseminated Intravascular Coagulation
|
0.330 |
Biomarker
|
disease |
CTD_human |
[Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin III].
|
6233579 |
1984 |
Disseminated Intravascular Coagulation
|
0.330 |
Therapeutic
|
disease |
CTD_human |
[Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin III].
|
6233579 |
1984 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
[A heterozygous point mutation G13328A in antithrombin gene causes thrombosis].
|
16620552 |
2005 |
Thrombophilia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We studied the prevalence of antithrombin III (AT III), protein C (PC) and protein S (PS) deficiencies and factor V Leiden mutation in thrombophilia in Taiwan.
|
9271815 |
1997 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
We studied the prevalence of antithrombin III (AT III), protein C (PC) and protein S (PS) deficiencies and factor V Leiden mutation in thrombophilia in Taiwan.
|
9271815 |
1997 |
Nephrotic Syndrome
|
0.500 |
Biomarker
|
group |
CTD_human |
We studied plasma antithrombin III (AT-III), alpha 1-PI, alpha 2-antiplasmin (alpha 2-A), alpha 2-macroglobulin (alpha 2-M) activity, and some blood coagulation and fibrinolysis tests in children with frequently relapsing prednisone-responsive NS.
|
11304663 |
2001 |
Deep Vein Thrombosis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
We screened 1950 deep vein thrombosis (DVT) patients for AT activity and antigen levels.
|
25811371 |
2015 |
Deep Vein Thrombosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We report here the first heterozygous deletion of SERPINC1 exon 1 identified in a 44-year-old man with type I deficiency who developed deep vein thrombosis of the left leg complicated by pulmonary embolism.
|
25083771 |
2015 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report 22 novel antithrombin gene (SERPINC1) mutations associated with antithrombin deficiency in 17 French and five German families.
|
16705712 |
2006 |
Thrombosis of renal vein
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We present a case of renal vein thrombosis in a female newborn with normal plasma levels of protein C, protein S and antithrombin III, but with her genotype characterized by the presence of three prothrombotic risk factors: factor V Leiden, methylentetrahydrofolate reductase and platelet glycoprotein IIIa polymorphisms.
|
11344677 |
2001 |
Venous Thromboembolism
|
0.400 |
GeneticVariation
|
phenotype |
BEFREE |
We performed a meta-analysis with trial sequential analysis to investigate the associations between the endothelial cell-activated protein C receptor (EPCR) rs9574, F11 rs2289252, F11 rs2036914, FGG rs2066865, FGG rs1049636, CYP4V2 rs13146272, SERPINC1 rs2227589, and GP6 rs1613662 polymorphisms with the risk of VTE.
|
28353616 |
2017 |
Venous Thromboembolism
|
0.400 |
GeneticVariation
|
phenotype |
BEFREE |
We investigated the VTE risk associated with SNPs in the GP6 (rs1613662), SERPINC1 (rs2227589), F11 (rs2036914 and rs2289252), FGG (rs2066865), and F12 (rs1801020) genes.
|
23150947 |
2013 |
Thalassemia
|
0.010 |
Biomarker
|
group |
BEFREE |
We investigated changes in PC, protein S (PS), antithrombin III (AT III) and soluble endothelial protein C receptor (sEPCR) in thalassemia.
|
30384036 |
2018 |
Deep Vein Thrombosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
We investigated SERPINC1 defects in Japanese patients with congenital AT deficiency who developed venous thromboembolism or had a family history of deep vein thrombosis.
|
31030036 |
2019 |
Venous Thromboembolism
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
We investigated SERPINC1 defects in Japanese patients with congenital AT deficiency who developed venous thromboembolism or had a family history of deep vein thrombosis.
|
31030036 |
2019 |
Deep Vein Thrombosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We have identified 2 novel polymorphisms, g.25G>A and g.-1A>T, and 2 known g.67G>A and rs3138521 5' UTR polymorphisms in SERPINC1 regulatory region in Indian patients with DVT for the first time.
|
27279637 |
2017 |
Pyruvate Carboxylase Deficiency Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found 22 (48%) patients with the SPS, 11 (24%) with the aPCR phenotype, 5 (11%) with the factor V Leiden mutation, 7 (15%) with the prothrombin gene mutation, 29 (63%) with the MTHFR gene mutation, 11 (24%) with the factor V HR2 haplotype, 11 (24%) with antiphospholipid antibodies, 4 (9%) with PS deficiency, 6 (13%) with PC deficiency, one with the FV Hong Kong mutation, and one with AT-III deficiency.
|
15609280 |
2005 |
Methylenetetrahydrofolate reductase gene mutation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found 22 (48%) patients with the SPS, 11 (24%) with the aPCR phenotype, 5 (11%) with the factor V Leiden mutation, 7 (15%) with the prothrombin gene mutation, 29 (63%) with the MTHFR gene mutation, 11 (24%) with the factor V HR2 haplotype, 11 (24%) with antiphospholipid antibodies, 4 (9%) with PS deficiency, 6 (13%) with PC deficiency, one with the FV Hong Kong mutation, and one with AT-III deficiency.
|
15609280 |
2005 |